Literature DB >> 16677631

Intravitreal injection of endothelin-1 caused optic nerve damage following to ocular hypoperfusion in rabbits.

Masaaki Sasaoka1, Takazumi Taniguchi, Masamitsu Shimazawa, Naruhiro Ishida, Atsushi Shimazaki, Hideaki Hara.   

Abstract

The purpose of this study was to investigate the time course of the ocular hypoperfusion, retinal damage, and optic nerve damage induced by intravitreal injection of endothelin-1 (ET-1) in rabbits. ET-1, at 5 pmol (20 microL, twice a week for 2 or 4 weeks), was injected from the pars plana into the posterior vitreous of the right eye. Optic nerve head (ONH) blood flow and retinal artery diameter, together with the neurofilament light chain (NF-L) content, retinal morphology, and axon density of the optic nerve, were evaluated at 2, 4, and 8 weeks after the first injection of ET-1 (n=7 or 8). Tissue blood velocity in ONH was measured using a laser speckle method, and the diameter of major retinal arteries on the rim of the ONH was calculated from fundus photographs by a masked observer. Histological analysis and immunoblot evaluation of NF-L in the optic nerve were performed to evaluate optic nerve damage. At 2 weeks after the first ET-1 injection, tissue blood velocity was decreased by approximately 20% (versus the contralateral eye), and the diameter of retinal arteries had decreased by approximately 40%. These changes were sustained at the same level until 8 weeks after the first ET-1 injection. At 4 and 8 weeks after the first ET-1 injection, the amount of NF-L in the optic nerve was significantly less in the ET-1 treated eyes than in the contralateral eyes. At 8 weeks after the first ET-1 injection, a loss of myelinated axons and increases in gliosis and connective tissue were noted in the optic nerve of the treated eye, and the optic nerve-axon number had decreased significantly (each, versus the untreated eye). Retinal ganglion cells in the retina were not observed any damage at 2, 4, and 8 weeks after ET-1 injection. In conclusion, intravitreal injection of ET-1 induced chronic hypoperfusion in the ONH and retina, which presumably caused decreases in NF-L content and axon number in the optic nerve noted in the later part of the observation period.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16677631     DOI: 10.1016/j.exer.2006.03.007

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  10 in total

Review 1.  Intrinsic axonal degeneration pathways are critical for glaucomatous damage.

Authors:  Gareth R Howell; Ileana Soto; Richard T Libby; Simon W M John
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

Review 2.  Differential gene expression in glaucoma.

Authors:  Tatjana C Jakobs
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

3.  Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma.

Authors:  Gareth R Howell; Katharine H MacNicoll; Catherine E Braine; Ileana Soto; Danilo G Macalinao; Gregory L Sousa; Simon W M John
Journal:  Neurobiol Dis       Date:  2014-08-15       Impact factor: 5.996

4.  Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma.

Authors:  Gareth R Howell; Danilo G Macalinao; Gregory L Sousa; Michael Walden; Ileana Soto; Stephen C Kneeland; Jessica M Barbay; Benjamin L King; Jeffrey K Marchant; Matthew Hibbs; Beth Stevens; Ben A Barres; Abbot F Clark; Richard T Libby; Simon W M John
Journal:  J Clin Invest       Date:  2011-03-07       Impact factor: 14.808

Review 5.  Effects of Tafluprost on Ocular Blood Flow.

Authors:  Xinyue Zhang; Xiaoyu Zhou; Yang Zhao; Xiang Yang; Dengming Zhou; Baihua Chen; Xuanchu Duan
Journal:  Ophthalmol Ther       Date:  2022-09-15

6.  Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye.

Authors:  Naoko Aizawa; Hiroshi Kunikata; Yukihiro Shiga; Satoru Tsuda; Yu Yokoyama; Kazuko Omodaka; Tomoki Yasui; Keiichi Kato; Hiroaki Kurashima; Etsuyo Miyamoto; Masayo Hashimoto; Toru Nakazawa
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

7.  Neurofilament light chain in the vitreous humor of the eye.

Authors:  Manju L Subramanian; Viha Vig; Jaeyoon Chung; Marissa G Fiorello; Weiming Xia; Henrik Zetterberg; Kaj Blennow; Madeleine Zetterberg; Farah Shareef; Nicole H Siegel; Steven Ness; Gyungah R Jun; Thor D Stein
Journal:  Alzheimers Res Ther       Date:  2020-09-17       Impact factor: 6.982

8.  Vascular derived endothelin receptor A controls endothelin-induced retinal ganglion cell death.

Authors:  Olivia J Marola; Gareth R Howell; Richard T Libby
Journal:  Cell Death Discov       Date:  2022-04-16

Review 9.  New directions in the treatment of normal tension glaucoma.

Authors:  Brian J Song; Joseph Caprioli
Journal:  Indian J Ophthalmol       Date:  2014-05       Impact factor: 1.848

10.  Endothelin 1-induced retinal ganglion cell death is largely mediated by JUN activation.

Authors:  Olivia J Marola; Stephanie B Syc-Mazurek; Gareth R Howell; Richard T Libby
Journal:  Cell Death Dis       Date:  2020-09-26       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.